To further expand its footprint in the anaesthetics field, healthcare solutions provider Aspen Pharmacare has signed agreements with a number of GlaxoSmithKline’s (GSK’s) subsidiaries to acquire a portfolio of anaesthetics globally. The portfolio, which comprises five established medicines, including Ultiva and four muscle relaxants Nimbex, Mivacron, Tracrium and Anectine, will further tie in with the company’s expansion strategy into niche therapeutic categories that complement its existing operations.
Source: www.engineeringnews.co.za
Aspen to play in anaesthetics field through acquisitions
Made with by iNCO Creative.